Pyxis Oncology, Inc. (PYXS)

Pyxis Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	12.76	19.47	9.66	179.29	274.74	8.08
Short-Term Investments	92.67	107.46	109.63	-	-	-
Cash & Short-Term Investments	105.43	126.93	119.3	179.29	274.74	8.08
Cash Growth	-32.86%	6.40%	-33.46%	-34.74%	3300.19%	-58.96%
Other Receivables	-	-	-	0.6	-	-
Receivables	-	-	-	0.6	-	-
Prepaid Expenses	4.97	0.76	1.01	1.31	1.76	0.01
Restricted Cash	1.47	1.47	1.47	1.47	1.47	-
Other Current Assets	-	3.28	2.82	3.94	0.7	0.02
Total Current Assets	111.87	132.44	124.6	186.61	278.67	8.1
Property, Plant & Equipment	21.45	22.14	24.81	24.77	1.24	1.94
Other Intangible Assets	2.54	2.6	24.31	-	-	-
Other Long-Term Assets	-	-	-	-	0.11	0.11
Total Assets	135.87	157.18	173.73	211.38	280.02	10.15
Accounts Payable	2.85	4.86	3.9	7.1	11.95	1.08
Accrued Expenses	10.08	10.73	12.62	23.45	6.33	1.88
Current Portion of Leases	1.51	1.45	1.23	-	0.17	0.62
Current Unearned Revenue	-	-	7.66	-	-	-
Other Current Liabilities	-	0.64	0.36	1.09	0.27	0.12
Total Current Liabilities	14.43	17.68	25.76	31.63	18.71	3.69
Long-Term Leases	18.33	18.75	20.1	18.92	-	0.17
Long-Term Deferred Tax Liabilities	-	-	2.16	-	-	-
Total Liabilities	32.76	36.43	48.02	50.56	18.71	3.85
Common Stock	0.06	0.06	0.05	0.03	0.03	0
Additional Paid-In Capital	487.71	484.08	411.82	373.23	353	0.1
Retained Earnings	-384.71	-363.56	-286.23	-212.44	-91.72	-15.74
Comprehensive Income & Other	0.05	0.17	0.06	-	-	-
Total Common Equity	103.1	120.75	125.7	160.82	261.31	-15.65
Shareholders' Equity	103.1	120.75	125.7	160.82	261.31	6.3
Total Liabilities & Equity	135.87	157.18	173.73	211.38	280.02	10.15
Total Debt	19.84	20.2	21.33	18.92	0.17	0.78
Net Cash (Debt)	85.59	106.73	97.97	160.37	274.57	7.3
Net Cash Growth	-37.18%	8.95%	-38.91%	-41.59%	3661.23%	-62.90%
Net Cash Per Share	1.41	1.83	2.46	4.85	32.33	7.08
Filing Date Shares Outstanding	61.95	61.59	58.13	36.83	32.22	1.29
Total Common Shares Outstanding	61.63	59.97	44.75	34.96	32.17	1.29
Working Capital	97.44	114.76	98.85	154.98	259.97	4.41
Book Value Per Share	1.67	2.01	2.81	4.60	8.12	-12.13
Tangible Book Value	100.56	118.15	101.4	160.82	261.31	-15.65
Tangible Book Value Per Share	1.63	1.97	2.27	4.60	8.12	-12.13
Machinery	-	4.19	4.52	3.28	1.9	1.36
Construction In Progress	-	-	-	9.18	-	-
Leasehold Improvements	-	10.74	10.96	0.53	0.23	0.21

Updated May 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q